Rongchang Chen Selected Research

Toluene 2,4-Diisocyanate (Toluene Diisocyanate)

1/2022	Prevention of IL-6 signaling ameliorates toluene diisocyanate-induced steroid-resistant asthma.
5/2021	Anti-DLL4 ameliorates toluene diisocyanate-induced experimental asthma by inhibiting Th17 response.
7/2020	Toll-like Receptor 4 Deficiency Aggravates Airway Hyperresponsiveness and Inflammation by Impairing Neutrophil Apoptosis in a Toluene Diisocyanate-Induced Murine Asthma Model.
7/2019	Corrigendum to "Transient Receptor Potential Ion Channels Mediate Adherens Junctions Dysfunction in a Toluene Diisocyanate-Induced Murine Asthma Model".
1/2019	IL-17F, rather than IL-17A, underlies airway inflammation in a steroid-insensitive toluene diisocyanate-induced asthma model.
1/2019	Transient Receptor Potential Ion Channels Mediate Adherens Junctions Dysfunction in a Toluene Diisocyanate-Induced Murine Asthma Model.
1/2019	Blockade of the NLRP3/Caspase-1 Axis Ameliorates Airway Neutrophilic Inflammation in a Toluene Diisocyanate-Induced Murine Asthma Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rongchang Chen Research Topics

Disease

41	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 11/2013
17	Asthma (Bronchial Asthma) 05/2022 - 11/2018
10	Inflammation (Inflammations) 05/2022 - 01/2019
10	Respiratory Insufficiency (Respiratory Failure) 01/2021 - 12/2014
6	Dyspnea (Shortness of Breath) 12/2021 - 12/2014
5	Respiratory Hypersensitivity 01/2022 - 01/2019
5	COVID-19 01/2021 - 01/2020
4	Airway Remodeling 03/2022 - 01/2018
4	Hypoxia (Hypoxemia) 01/2021 - 01/2013
4	Pneumonia (Pneumonitis) 01/2021 - 01/2014
4	Infections 01/2018 - 01/2006
4	Lung Injury 06/2017 - 01/2016
3	Fibrosis (Cirrhosis) 07/2022 - 03/2021
3	Metaplasia 01/2022 - 01/2019
3	Disease Progression 12/2021 - 01/2021
3	Neoplasms (Cancer) 01/2021 - 01/2019
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2016 - 07/2015
3	Human Influenza (Influenza) 01/2016 - 01/2011
2	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2022 - 12/2014
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 07/2022 - 10/2017
2	Idiopathic Pulmonary Fibrosis 07/2022 - 01/2022
2	Reperfusion Injury 11/2021 - 02/2016
2	Myocardial Ischemia (Ischemic Heart Diseases) 11/2021 - 01/2013
2	Pathologic Processes 04/2021 - 02/2020
2	Diabetic Cardiomyopathies 03/2021 - 01/2020
2	Pulmonary Embolism 01/2021 - 08/2016
2	Wounds and Injuries (Trauma) 12/2020 - 01/2020
2	Occupational Asthma 11/2020 - 01/2019
2	Weight Loss (Weight Reduction) 01/2020 - 01/2016
2	Critical Illness (Critically Ill) 01/2020 - 07/2018
2	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2020 - 01/2019
2	Lung Neoplasms (Lung Cancer) 11/2017 - 03/2015
2	Paralysis (Palsy) 01/2017 - 01/2016
2	Cardiotoxicity 09/2016 - 01/2013
2	Respiratory Tract Infections (Respiratory Tract Infection) 12/2014 - 01/2011
1	Pulmonary Hypertension 09/2022
1	Connective Tissue Diseases (Connective Tissue Disease) 09/2022
1	Body Weight (Weight, Body) 07/2022
1	Anaphylaxis (Anaphylactic Shock) 01/2022

Drug/Important Bio-Agent (IBA)

8	GoldIBA 07/2021 - 04/2015
7	Toluene 2,4-Diisocyanate (Toluene Diisocyanate)IBA 01/2022 - 01/2019
6	CollagenIBA 07/2022 - 01/2019
6	AutoantibodiesIBA 01/2022 - 01/2019
6	Biomarkers (Surrogate Marker)IBA 12/2021 - 03/2015
6	CytokinesIBA 03/2021 - 11/2015
6	Immunoglobulin G (IgG)IBA 01/2021 - 01/2006
5	AntibodiesIBA 10/2020 - 01/2006
4	ChemokinesIBA 01/2022 - 11/2015
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2011
4	Biological ProductsIBA 07/2021 - 01/2018
4	Immunoglobulin M (IgM)IBA 01/2021 - 01/2019
4	Proteins (Proteins, Gene)FDA Link 06/2020 - 07/2017
3	Immunoglobulin E (IgE)IBA 01/2022 - 11/2018
3	SteroidsIBA 01/2022 - 01/2019
3	Bronchodilator Agents (Bronchodilators)IBA 12/2021 - 01/2019
3	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2020 - 11/2018
3	AutoantigensIBA 08/2020 - 09/2019
3	Oxygen (Dioxygen)IBA 01/2020 - 01/2018
3	VaccinesIBA 01/2020 - 01/2011
2	Bleomycin (Blenoxane)FDA LinkGeneric 07/2022 - 10/2017
2	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2022 - 10/2017
2	Peptides (Polypeptides)IBA 01/2022 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2021
2	InterleukinsIBA 01/2022 - 01/2019
2	AntioxidantsIBA 01/2022 - 03/2021
2	Interleukin-17 (Interleukin 17)IBA 07/2021 - 01/2019
2	16S Ribosomal RNAIBA 11/2020 - 01/2020
2	Therapeutic UsesIBA 11/2020 - 01/2020
2	Butyrates (Butyrate)IBA 11/2020 - 01/2020
2	AntigensIBA 08/2020 - 01/2019
2	Aggrecans (Aggrecan)IBA 06/2020 - 01/2019
2	Formoterol Fumarate (Oxis)FDA Link 01/2020 - 01/2018
2	SuspensionsIBA 01/2020 - 01/2018
2	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2020 - 01/2018
2	SmokeIBA 01/2020 - 11/2013
2	lipoarabinomannan (LAM)IBA 01/2020 - 01/2019
2	Ion Channels (Ion Channel)IBA 07/2019 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2016 - 12/2014
1	Transforming Growth Factor beta (TGF-beta)IBA 07/2022
1	(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA 07/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2022
1	indium-bleomycinIBA 07/2022
1	MicroRNAs (MicroRNA)IBA 05/2022
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 03/2022
1	transgelinIBA 03/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Methacholine Chloride (Methacholine)FDA Link 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	shenkangIBA 01/2022
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2022

Therapy/Procedure

22	Therapeutics 07/2022 - 01/2011
8	Noninvasive Ventilation 01/2021 - 01/2016
7	Artificial Respiration (Mechanical Ventilation) 10/2020 - 01/2016
5	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2019 - 01/2017
4	Drug Therapy (Chemotherapy) 09/2020 - 01/2015
4	Mechanical Ventilators (Ventilator) 01/2020 - 01/2016
3	Metered Dose Inhalers (Metered Dose Inhaler) 01/2020 - 01/2018
2	Lung Transplantation 09/2022 - 01/2021
2	Emergency Treatment 01/2022 - 01/2018
1	Premedication 01/2022